Performance and Performance Persistence of "Ethical" Unit Trusts in the UK by Gregory, Alan & Whittaker, Julie
 
 
 
 
 
Performance and Performance Persistence of “Ethical” Unit 
Trusts in the UK 
 
 
 
 
Alan Gregory* 
Julie Whittaker** 
 
 
 
Paper Number: 05/04 
 
 
 
November 2005 
 
 
 
*Centre for Finance and Investment (Xfi) 
**Department of Management 
 
School Of Business and Economics 
University of Exeter  
 
First draft.  Please do not quote without permission 
 
We would like to thank colleagues and seminar participants at the University of 
Exeter for their comments on an earlier version of this paper, Richard Harris for his 
helpful suggestions on test statistics, and Maria Michou for her assistance with 
updating the Fama French and Momentum factors used in this paper.  The usual 
caveats with respect to errors and omissions apply. 
 
 2
Performance and Performance Persistence of “Ethical” Unit 
Trusts in the UK 
 
 
Abstract 
 
 
Using UK style portfolios that are free of any survivorship bias we examine 
performance, and persistence in the performance, of UK “ethical” or SRI funds, and 
compare them to a control group of non-SRI funds.  In addition, given evidence that 
many UK funds which claim to be international in nature may exhibit home bias in 
their portfolio allocations, we propose a new measure for performance of international 
funds that allows for this and show that such recognition has important implications 
for the conclusions drawn on performance.  We show that SRI funds have less 
exposure to HML, but greater exposure to SMB and momentum factors, and that 
neither SRI nor non-SRI funds exhibit significant under performance on a risk/style 
adjusted basis, despite comparatively poor absolute performance.  We also show that 
performance appears to be time-varying, and that conclusions on performance itself 
are influenced by whether a static or time varying model is employed.  We then 
examine persistence in fund performance and find evidence that supports persistence.  
In addition, we find there are differences in performance persistence between ethical 
and non-ethical funds, but conclusions on the degree of persistence and the direction 
of persistence appear to depend on the performance metric chosen.  However, it is 
always the case that past winner “ethical” funds outperform “loser” ethical funds at 12 
month horizons, such that there is evidence that “ethical” investors can enhance 
investment performance by investing in past “winners” and avoiding past “losers”. 
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Performance and Performance Persistence of “Ethical” Unit 
Trusts in the UK 
 
 
Introduction 
 
Increasingly market choices are being made that reflect attitudes to social issues.
1
 
Within financial markets, investors can give some expression to their social concerns 
by depositing money in companies that meet certain ethical criteria. Investing in such 
a manner requires additional information and accordingly a large proportion of 
socially responsible investment (SRI) is conducted through institutions, charities, 
churches, pension funds and insurance companies. However, ethical unit trusts, now 
more commonly referred to as SRI funds, provide a means for individuals to invest 
sums according to ethical criteria without personally engaging in company research 
and the market for these funds is growing. Within the UK, for most years during the 
decade 1989-1999, the value of SRI unit trusts grew at a faster annual rate than the 
whole unit trust market. In 2003 it was valued at a minimum of £4.2 billion, an 
increase of over 25% since 2000 (EIRIS, 2005). 
 
Although some investors in SRI funds are willing to accept lower returns for their 
moral stance (Lewis and Mackenzie (2000), Webley, Lewis and Mackenzie (2001)), 
the performance of SRI funds vis-à-vis non-SRI funds remains of interest. First, 
growth in the SRI sector will require funds to appeal to a wider group of investors 
than those with a combination of strong principles and an income level that can 
support potentially suboptimal returns.  Second, the effects of ethical criteria on 
financial performance have relevance for company strategy. Third, there is intellectual 
curiosity in considering the performance of funds chosen from a restricted universe of 
companies.  Initially, ethical funds were developed through a negative screening 
process resulting in the exclusion of stocks of companies engaged in, for example, 
gambling, tobacco, and human right abuses. Then choice of stocks began to be made 
on the basis of positive criteria too, such as the inclusion of companies which engage 
in environmental management. This positive screening permits the inclusion of larger 
companies which were typically more likely than small companies to be excluded by 
                                                
1
 See for example, Harrison, Newholm and Shaw (2005). 
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negative screening.  Therefore, although still restrictive, the universe for SRI funds 
has been enlarged. 
 
Previous empirical work on SRI unit trusts in the UK (Luther, Matatko and Corner 
(1992); Luther and Matatko (1994); Mallin, Saadouni and Briston (1995); Gregory, 
Matatko and Luther (1997)) have attempted to understand whether performance can 
be explained by ethical criteria or by other factors such as fund size and composition. 
With regard to composition of funds the main area of interest has been company size, 
since larger firms by virtue of their diversity, are more likely to breach ethical criteria. 
Only Gregory et al. (1997) conducted comparative work using time series and cross 
series regressions, which also included risk adjusted benchmarks. Their results 
tentatively suggested that SRI funds did not perform as well as other funds, but that 
this could be explained by their greater exposure to ‘small firms’ risk rather than 
ethical criteria per se. Empirical work on US SRI funds by Hamilton, Jo and Statman 
(1993) found no significant difference in performance compared with conventional 
funds. This result was endorsed by cointegration testing by Reyes and Grieb (1998), 
although they also found that SRI funds did not share a common underlying time 
trend with other funds. Geczy, Stambaugh and Levin (2003) compared optimal 
portfolios of funds with SRI objectives and those without, concluding that SRI 
constraints, is costly when fund managers are skilled. Bauer Koedijk, and Otten 
(2005), working with US, UK and German data found little significant difference in 
the performance of SRI  and conventional funds, while discerning that older SRI 
funds performed better than younger ones, indicative of a learning effect.    
 
In this paper, we build on some interesting innovations in Bauer et al (2005).  That 
paper looked at differences in style between ethical and ordinary mutual funds, and 
also investigated performance of international funds.  First, we use UK style 
portfolios that, by construction, are free of any survivorship bias.  Second, we propose 
a very different measure for performance of international funds that picks up “home 
bias” in investment allocations.  It turns out that the use of such a performance metric 
changes the finding in Bauer et al (2005) of outperformance by UK funds. Third, we 
show that performance appears to be time-varying, and that conclusions on 
performance itself are influenced by whether a static or time varying model is 
employed. Fourth, as in Blake and Timmerman (1998) and Fletcher and Forbes 
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(2002) we examine persistence in fund performance and find results supportive of 
those in Otten and Bams (2002).  However, we find there are differences in 
performance persistence between ethical and non-ethical funds, and that, as in 
Fletcher and Forbes (2002) conclusions on the degree of persistence appear to depend 
on the performance metric chosen.  Overall, our findings do not suggest that ethical 
investors lose out compared to “ordinary” investors, but absolute returns are low and 
the style exposure of ethical funds looks very different to that of ordinary funds. 
 
Data 
 
For each year from Jan 89 to Dec 02, we collected returns for all 32 ethical unit trusts 
that have existed in the UK up until that point, whether alive or dead
2
.  At the end of 
the sample period, dead funds comprised 12.5% of all funds that had been in 
existence.  For each of these funds, we formed a randomly selected but characteristic-
matched portfolio of 5 non-ethical unit trusts.  The matching criteria were: 1. the fund 
should have a start date within 6 months of the ethical UT with which it is matched, 
and; 2. the fund should be in the same AUTIF category.  Where (1) could not be met, 
the start date was relaxed to within 9 months. 
 
The most striking element of summary data is that 29.93% of our control sample die 
before the end of the sample period
3
 compared with the relatively low rate of demise 
for ethical funds.  Blake & Timmerman’s (1998) sample (admittedly for a longer 
period, 72-95) shows a non-survival rate of 41%, so the low failure rate of “ethicals” 
or SRI funds is remarkable in this context. 
 
Our first tests involve calculating average returns and wealth relatives.  Here, our tests 
are equivalent to forming each month: 1. an equally weighted “fund of funds” of all 
UTs available at that date; 2. a “hedge” portfolio, equivalent to a long position in the 
ethicals fund of funds and a short position in the non-ethicals fund of funds.   
 
                                                
2
 Note: Bauer et al (2005), who are also careful to control for survivorship bias in their sample of SRI 
funds, have an identical number of ethical funds. 
3
 Bauer et al (2005) using a slightly shorter period (1990-2000) and different matching criteria report a 
similar figure, with 28% of their whole sample disappearing before the end of the measurement period. 
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Measuring Unit Trust Performance  
One approach is to measure performance using either a single, three factor or four 
factor model. The standard Fama-French three factor model has factors which are the 
excess return on the market Rmt - rft,  the returns on a size factor  SMBt (the difference 
between the returns on a portfolio of small companies and a portfolio of large 
companies) and a book-to-market factor HMLt which is the difference in returns on a 
portfolio of high book-to-market companies and low book-to-market companies. The 
four factor model adds a momentum factor MOMt, the difference in returns between a 
“winner” portfolio and a “loser” portfolio, formed on the basis of the previous 12 
months’ returns.  The 4-factor model
4
 can be described as: 
 
( )                         +  pitp1 ελδγβα +++−+=− MOMHMLSMBRRRR tptpftmtppftpt (1) 
 
This model can be estimated for each fund or portfolio p over the full t data periods, 
when under null hypothesis of no-abnormal performance the αp coefficient should be 
equal to zero. A potential problem with this approach is that it imparts some look-
ahead bias if funds are required to survive for a certain minimum number of months 
in order to be incorporated into the sample.  Besides the obvious problem that such a 
bias presents for any investigation, it could have particularly serious implications for a 
study using a small number of funds where survivorship differs between the SRI and 
non-SRI sub-samples. 
 
For that reason, we estimate equation (1) by regressing an equally-weighted portfolio 
of excess returns on the unit trusts in calendar time. As Blake and Timmermann 
(1998) point out, this avoids making any assumption about the cross-section 
relationship of returns between funds.  This approach is analogous to that proposed 
for event tests by Fama (1998) and Mitchell and Stafford (2000).  The alternative, 
which avoids any look ahead bias, is to run equation (1) for individual funds on a 
rolling basis for months t=T to t=T+36, then use the stored regression coefficients to 
calculate the abnormal performance for month T+37.  This has the advantage of 
enabling performance to be observed for each fund without incorporating any look 
                                                
4
 1 and 3 factor models amount to special cases of the 4-factor model with the coefficient on MOM 
(and SMB and HML in the case of the single factor model) constrained to equal zero. 
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ahead bias.  In these regressions we require the fund to have a minimum of 18 months 
prior returns in order to estimate the coefficients for month T+37.  This rolling 
regression approach can also be employed for calendar time portfolios.  The 
regressions are run for successive over-lapping 36 month periods  starting in January 
1989.  To test the hypothesis that the Jensen alphas and other coefficients from these 
rolling regressions are significantly different from zero required a t-statistic that is 
robust to the overlapping nature of the data.   This can be achieved by running a 
regression of the estimated alphas (or other coefficients) on a constant, with the test 
statistic being estimated by the Newey-West procedure allowing for the 35 
overlapping observations.  We also separate our sample into two equal periods (with 
66 months in each) and estimate Wald statistics to test for performance differences 
between first and second halves, once again allowing for overlapping observations 
using a Newey-West procedure.
5
 
 
Alternative approaches to time-varying performance are either to test directly for 
market timing skill, or to estimate a conditional model.  The Treynor-Mazuy test for 
market timing includes a quadratic term in the return regression so that successful 
timing is indicated by a positive coefficient on the squared market return term.  A 
similar logic can be applied to exposure to the other factors.  
 
Rpt - rf =αp+βp(Rmt -rf)+γpSMBt+δpHMLt+λpMOMt +ηp(Rmt - rf)2+φp(SMBt)2+  
+ϕp(HMLt)2+κp(MOMt)2+εpt       (2) 
 
Alternatively, Ferson and Schadt (1996) have proposed a conditional performance 
model, the rationale being that publicly available information has a role in 
determining future returns, in which case we might expect managers to make use of 
this to time-vary their market exposure. Under a conditional CAPM, the regression 
becomes 
 
( ) [ ]( )                           + it110 εββα ftmttpftmtppftpt RRzRRRR −′+−+=− −    (3) 
 
                                                
5
 The authors are grateful to Richard Harris for these suggestions on significance testing. 
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where zt-1 = Zt-1 - E(Z) is a vector of deviations of the Zs from their unconditional 
means. Instruments used are: the lagged treasury bill rate, the lagged dividend yield, 
the slope of the term structure (difference between long and short run government 
bond yields), and a dummy variable for January.  In addition, we estimate a three and 
four factor version of this model.  These are conceptually different tests from the 
rolling regression tests described previously.  Under the conditional model, time 
varying exposures occur in response to publicly available information.  The market 
timing model is silent on whether changes in risk exposure are in response to publicly 
available information, but measures the success of timing through the factor return 
squared terms.   By contrast, the rolling regressions simply allow factor exposures to 
change through time, with no priors on what these changes may or may not be in 
response to. 
 
The above are perfectly reasonable models for estimating domestic fund performance, 
but 12 out of our 32 ethical funds are “international”.  One alternative is to simply run 
the above regressions using a suitable world index.  However, inspection of the 
investment strategies of these funds shows evidence of home bias and considerable 
variation in the degree of this bias between the funds.  This home bias can be 
measured by extending the four factor model in (1) to incorporate home bias not only 
in the exposure to the domestic market, but also in the domestic, SMB, HML and 
MOM factors.  We investigate various proxies for the world factors, with the most 
successful appearing to be the use of the MSCI World index and the US factors from 
Kenneth French’s web page, translated into sterling returns.  We then measure home 
bias for each factor as (HOMEFACTOR – WORLDFACTOR), which we describe as 
(Rw-Rm), SMBd, HMLd and MOMd respectively, giving the following model: 
 
( )
( )                         + 
+  
pitp1
p1
ελδγβ
λδγβα
+++−
+++−+=−
MOMdhHMLdhSMBdhRRw
MOMwwHMLwwSMBwwRRwRR
tppmtwtp
tptpftwtppftpt
         (4) 
 
In addition to testing for evidence of fund out-performance, we also examine the 
consistency or persistence of fund performance.  Given the small number of SRI 
funds here we use the contingency table tests common in the literature (for a UK case 
applied to unit trusts, see Fletcher and Forbes, 2002).  We classify funds as winners or 
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losers in each of two consecutive time periods (which can be 1 month, 3 month, 6 
month or 12 months), and then count the number of successive periods’ winners or 
losers, resulting in a four way classification based upon two-period performance, 
namely: winner-winner (WW), winner-loser (WL), loser-winner (LW), and loser-
loser (LL). We compute the number of combinations and the following related 
statistics (see Carpenter and Lynch, 1999): the percentage of repeat winners, PRW = 
WW/(N/2), with a Chi-Squared test with 1 d.o.f. where CHI = {(WW - N/4)
2
 + (WL - 
N/4)
2
  + (LW - N/4)
2
 (LL - N/4)
2
}/N/4 (we also compute these figures for the 
difference between SRI and non-SRI funds); and the cross-product ratio CP = (WW x 
LL)/(WL x LW) which we test using the log-odds ratio of Brown and Goetzman 
(1995) and Fletcher and Forbes (2002). 
 
We do not use decile portfolios (as in Otten and Bams, 2002) here because of the low 
number of ethical funds.  Instead, we perform two types of test, in keeping with 
Fletcher and Forbes (2002).  First, for all funds, segregated into domestic and 
international, we form winner-loser portfolios and report results on that basis.  
Second, for the domestic group, as in Blake and Timmerman (1998) we form quartile 
(rather than decile) portfolios, and report results on that basis. Given the small number 
of international ethical funds, we do not undertake this latter analysis for those 
groups.  We define “winners” and “losers” by the following means: Jensen alphas 
from the 3 factor and 4 factors models, and; absolute returns.  Note that in all cases 
we define cut-offs across the whole sample, not separately for SRI and non-SRI 
groups. 
 
Results 
Our first results (Table 1) record results based upon the absolute performance of the 
funds on a calendar time portfolio (with equal weightings) basis.  These record a 
disappointing level of performance for all funds relative to market benchmarks.  For 
domestic funds, the ethical (SRI) funds under-perform non-SRI funds by 0.56% p.a., 
but have lower absolute risk (13.8% standard deviation versus 15.6% for the non-SRI 
funds).  The wealth-relative figures show the cumulated value of the calendar funds at 
the end of December 2002.  The performance of the international funds are 
particularly disappointing, and here the SRI funds under-perform the control group of 
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non-SRI funds by around 1% p.a..  Furthermore, the risk of these funds is marginally 
higher than that of the control group (14.95% standard deviation versus 14.68%).   
 
In Table 2 we report results from a basic Jensen alpha model run in calendar time.  
We report these for single, three and four factor models.  We also report results for 
“hedge” portfolios which are long in SRI funds and short in non-SRI funds. Turning 
to the domestic funds, the first message from the results is that none of the alphas are 
significant under any model.  As might be expected from the absolute results reported 
in Table 1, performance is marginally negative for both SRI and control group funds, 
but never significantly so.  Furthermore, there are no differences in the alphas 
between the two groups of funds under any of the models.  Our results are not 
qualitatively different from those of Bauer et al, although our alphas are considerably 
closer to zero.  This reflects differences in our market indices (FTASI versus 
Worldscope) and factor construction, which, in contrast to those based upon 
Worldscope figures, are based on Datastream figures including those from the dead 
companies file, which should avoid any survivorship bias being present in our factors.  
We find that there are significant differences in style/factor exposures.  First, SRI 
funds have lower market exposures.  Betas are close to unity for the control group, but 
significantly less than unity for the SRI funds.  The difference in betas is highly 
significant under all three models.  Second, the size-exposure is significantly positive 
for both groups, but the SRI funds have significantly greater exposure to this factor.  
The SRI funds have an insignificant negative exposure to the HML factor, whereas 
the non-SRI group have a significant positive exposure; the difference between the 
groups is significantly negative.  Last, whilst neither group of funds has significant 
exposure to the momentum factor, we find that SRI funds have a significantly greater 
exposure to the factor.  Although our findings in respect of differences in market risk, 
SMB and HML factor loadings are similar to those of Bauer et al, there are differences 
in a number of respects.  First, the factor loadings on SMB, HML and MOM are 
different in magnitude and tend to be less significant for both groups.  Second, our 
finding on differences in momentum exposure contrast to theirs. 
 
For the international funds, our approach reveals significant home bias in exposures to 
market and SMB factors for SRI and non-SRI funds, although the significance level is 
slightly over 5% for the latter.  Both groups also have significant exposure to 
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international market and SMB factors.  However, there is no significant exposure to 
HML, either domestically or internationally, for either group.  Extending the analysis 
to a four factor model adds nothing, and exposure to the momentum factor (home bias 
and international) is always insignificant.  We also show negative but insignificant 
alphas of around 0.1% per month for both SRI and non-SRI funds.  The only 
significant factors on the hedge fund are that both international SMB exposure and 
home bias in SMB exposure are positive, which is in line with the finding from the 
domestic analysis which illustrated that “ethical” funds have greater exposure to size 
effects.  Our results stand in some contrast to Bauer et al, (Table 5, p.1761) who 
report insignificant positive alphas, significant HML and momentum exposures, and 
significant differences on all factor exposures between SRI and non-SRI groups.  
 
In Table 3, we investigate timing effects using the Treynor-Mazuy approach and a 
Ferson-Schadt style conditional model.  Two general observations are in order before 
discussing the detail of the analysis.  The first is that whilst potentially interesting 
findings arise with result to timing ability, in no case does an analysis based on either 
of these approaches change our general conclusions with regard to factor exposures 
and performance.  The second is that in no cases are any of the time varying 
coefficients significant for the international funds.  For that reason, we do not report 
the timing effect regressions for these funds.
6
   Turning to the Treynor-Mazuy 
regressions, the market timing coefficient (Rm-Rf)
2
 is significantly negative for both 
SRI and non-SRI funds using any of our factor models.  Except in the case of the 
CAPM, where the negative difference is significant at the 10% level, there are no 
significant differences between SRI and non-SRI funds. There is no evidence of any 
timing ability with respect to the SMB factor, and neither is there any significant 
difference between funds in their ability to time exposure to SMB.  Intriguingly, 
however, both SRI and non-SRI funds appear to have the ability to time exposure to 
the HML factor and furthermore analysis of the hedge portfolio reveals that SRI funds 
have significantly superior ability to time this exposure.   At the same time, SRI funds 
have negative ability to time WML exposure, although they are not significantly 
worse than the non-SRI group in this regard. 
 
                                                
6
 Results are available from the authors on request. 
 12
The alternative approach to time varying returns, using the conditional asset pricing 
models, adds little to the analysis except to reveal that non-SRI funds exhibit a 
negative loading on the JAN(Rm-Rf) variable, suggesting that they under-perform in 
the month of January, though in this regard they are not significantly worse than the 
SRI funds. 
 
An alternative approach is to investigate time-varying performance by estimating 
regressions on a rolling basis.  Of course, a sub-period analysis could be used (as in 
Bauer et al) but running rolling regressions allows for continual variation in factor 
exposure and performance.  A further advantage is that next month’s abnormal 
performance can always be estimated for individual funds (as well as calendar 
portfolios) based upon the current estimates of their factor exposures.  The results in 
Table 4 show factor exposures for the calendar time portfolios based upon these 
rolling 36 month regression, along with the Newey-West test p-values described 
above.  These results reveal important differences from those reported in Tables 2 and 
3 above.  Perhaps the most important is that although rolling regressions confirm that 
neither SRI nor non-SRI funds exhibit significant out-performance, the results reveal 
that Domestic SRIs have significantly better performance than non-SRI funds using 
either the 3-factor or 4-factor models.  Consistent with the findings of Bauer et al, the 
Wald test result shows that this significantly superior performance arises in the second 
period rather than the first.  The “hedge change, second period” alpha is roughly 0.2% 
per month better than the first period alpha, whichever model is used.  This change in 
performance shows up clearly in Figures 1 (3-factor) and 2 (4-factor) which charts the 
alpha coefficients for SRI, non-SRI and hedge portfolios through time.  Turning to the 
factor exposures, the qualitative results for market and SMB exposures are 
unchanged, but non-SRI funds have a significant exposure to HML at only the 10% 
level under the 3-factor model, and exposure to the momentum factor of SRI funds is 
significantly positive at the 10% level.  All conclusions on differences in factor 
exposures (i.e. the hedge fund exposures) are unchanged under the rolling regressions.  
However, the Wald tests show that there are significant changes in the hedge fund 
exposure to market risk and WML between first and second periods.
7
  This suggests 
that relative to non-SRI funds, SRI funds appear to significantly increase their 
                                                
7
 Changes in respect of the SMB factor are only significant under the 3-factor model. 
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exposure to market risk and momentum in the second period.  The hedge fund 
coefficients are shown in Figures 4 (3-factor) and 5 (4-factor). 
 
Within the International funds, again important differences arise compared with those 
reported in Table 2.  First, non-SRI funds now significantly under-perform, by around 
a quarter of one percent a month, although the hedge results reveal no significant 
difference in performance (see also Fig. 3).  Second, on a time varying basis both SRI 
and non-SRI portfolios have significant positive exposure to international HML.  
Third, SRI funds exhibit significantly less exposure to home HML but more exposure 
to international HML. Last, our Wald tests reveal significant changes in exposure to 
the world market and size factors through time.  The plot of the factor exposures is 
illustrated in Figure 6.  Taken as a whole, our results in Table 4 suggest that it is 
important to allow for changes in style/factor exposure in performance measurement 
tests.  These changes can come about either because individual funds change their 
portfolios, or because the mix of funds within the portfolio changes.   
 
In Table 5 we report average monthly abnormal performance figures for individual 
funds calculated by running rolling regressions.  Like the calendar time portfolios 
these are free of survivorship bias in that they represent an implementable investment 
strategy, though unlike the calendar time funds the approach requires a fund to have 
been in existence for at least 18 months before its factor exposure can be calculated.  
Hence the Table 5 results are the average performance figures for funds which have 
met a pre-survival criterion.  The results present a simple pooled average for each 
model, together with simple T-tests and a T-test for differences (assuming unequal 
variances).  These results tend to contradict those of Table 2, but are not inconsistent 
with those of Table 4.  There are, however, differences between Table 4 and Table 5 
in terms of statistical significance.  Turning to the three factor model, the Table 5 
results show a significant positive abnormal performance for SRI funds of around 
0.2% per month, compared with an (insignificant) alpha value equivalent to about 
0.1% per month in Table 4.  The non-SRI mean is an insignificant but positive 0.06% 
per month, compared with an insignificant negative alpha.  However, the difference in 
performance between funds is similar (0.14% per month), although in contrast to the 
Table 4 results the difference is not significant here.  The 4-factor performance figure 
for both sets of funds in Table 5 is positive but not significantly different from zero.  
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The difference in performance is somewhat smaller than indicated by Table 4, and is 
statistically insignificant.  However, consistent with Table 4, none of the performance 
figures for international funds are significantly different from zero, and neither is the 
difference in performance significant.  The international multi-factor model reveals 
positive performance which is not significantly different from zero for either group of 
funds, and although SRIs out-perform the non-SRIs, the difference is not significantly 
different from zero. 
 
Overall, the results from Tables 1-5 can be summarised as follows.  Whilst the 
absolute performance of both sets of funds is disappointing, there is no evidence of 
any significant difference in performance, and little evidence of significant over or 
under performance on a risk-adjusted basis, however performance is measured.  There 
are clear risk differences between SRI and non-SRI funds, however.  Furthermore 
there is evidence of time variation in performance and risk exposures, coupled with at 
least some evidence that suggests allowing for this time variation is capable of 
changing conclusions. 
 
We now proceed to consider persistence in performance.  Given the evidence 
summarised above, we use the rolling performance and risk exposure data in these 
tests from both the 3 and 4 factor model analyses.  In addition, we look at what 
conclusions may be drawn if we use absolute performance to rank performance.  As 
explained above, we start with simple winner-loser portfolios, and these are presented 
in Tables 6 to 10 inclusive.  We measure four short-term performance horizons: one 
month; three months; 6 months; and 12 months.  We also show overall persistence 
(the SRI plus non-SRI funds) and persistence for SRI and non-SRI funds separately.  
Two tests are presented: a chi-squared test for differences between the distribution of 
repeat winners and repeat losers, together with the percentage of repeat winners 
(PRW), and the cross-product ratio (CP = (WW x LL)/(WL x LW)) together with a Z-
test on the CP ratio.  We also report whether PRW is significantly greater or lower 
between SRI and non-SRI funds.   
 
In Table 6 we present results for domestic funds using absolute returns to rank firms 
and measure subsequent performance.  Overall, we see significant persistence as 
measured by the chi-squared test at intervals of 6 and 12 months, though no 
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significance is observed using the CP test.  The SRI group exhibit significantly lower 
repeat winners than would be expected under the null hypothesis
8
 for both 6 and 12 
month horizons, though no significance is observed under the Z-test.  Inspection of 
the full matrix of results
9
 shows that this is because there are a high number of repeat 
losers coupled with a low number of repeat winners.  The CP ratio will tend to 
become significant when there is persistence in both winners and losers.  By contrast, 
there is a significant percentage of repeat winners amongst the non-SRI control funds 
for periods of 3, 6 and 12 months.  Furthermore, non-SRI funds show significantly 
more repeat winners than SRI funds for all performance measurement intervals.  
Intriguingly, these conclusions do not hold when persistence is examined under either 
the three or four factor models.  When we examine performance on a three-factor 
basis in Table 7, we see that overall there is some evidence of modest persistence at 1, 
6 and 12 month horizons, although this again shows through in the difference in 
percentage in repeat winners rather than through the CP ratio.  At the 1 month horizon 
both SRI and non-SRI funds exhibit a PRW ratio significantly less than 50%, with no 
significant difference between the groups.  At the 3 month horizon, SRI funds have a 
PRW ratio significantly greater than 50%, though this significance does not hold for 
longer periods.  The non-SRI funds have significantly less than 50% PRW for 3 and 6 
though significantly greater than 50% for 12 month horizons.  However for all 
horizons of 6 months and beyond they exhibit significantly less persistence than their 
SRI counterparts.   
 
When performance is measured on a 4-factor model the result is rather different.  As 
with the Fletcher and Forbes result, our conclusions on performance persistence alter 
when a 4-factor model is used, but in the opposite direction to their findings.  Here, 
we find greater evidence of persistence when we switch to a 4-factor model.  Given 
the clear evidence on time variation in performance and factor loadings, together with 
differences between factor returns between the first and second halves of our study 
period, we believe the most likely explanation for the difference in results is simple 
calendar time variation in fund behaviour (note that the Fletcher and Forbes analysis 
covers 1983-1996 in contrast to our 1989-2002 period), .  For our overall sample we 
find negative persistence at short horizons (1 and 3 months), but positive persistence 
                                                
8
 The expectation would, of course, be 50% under the null. 
9
 Not reported for reasons of space, but available from the authors on request. 
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at the 12 month horizon.  Furthermore, at this horizon the CP ratio is significant at the 
10% level.  For the SRI funds, we observe negative performance persistence at the 3 
month horizon, though no other horizons are significant.  For non-SRI funds we 
observe negative persistence at the 1 month horizon, with strong positive persistence 
at the 12 month horizon.  At 1 and 12 month horizons there is more persistence in 
non-SRI funds, but at 3 and 6 month horizons SRI funds show more persistence.  
Whilst some of these patterns are curious, it seems clear that switching from a three to 
a four factor model has a significant impact both on the PRW statistic and also on the 
differences in persistence between SRI and non SRI funds. 
 
Persistence tests for the International funds are reported in Tables 9 and 10.  Table 9 
shows the results based on absolute performance.  Results for the overall sample 
indicate that only at a 12 month horizon is significant persistence observed, and then 
only on the basis of a PRW test.  For the SRI sample, the PRW is less than 50% at the 
1 month horizon (with a chi squared test significant at the 10% level), greater than 
50% at the 3 month horizon (again with a chi squared test significant at the 10% 
level), with a significant PRW less than 50% at the 12 month horizon.  Whilst 
persistence is not significant at the 5% level for 1-6 month horizons, though 
significant at the 10% level with a PRW of 64.8% at the 12 month horizon, as with 
their domestic counter-parts the international non-SRIs always exhibit significantly 
greater persistence and higher PRWs than the SRI funds.  On a multi-factor basis 
(Table 10) overall significant persistence is observed at 1, 3 and 12 month horizons 
(at least at the 10% level) with PRWs being less than 50% for shorter periods, but 
greater than 50% for the 12 month horizon.  SRI funds exhibit marginally significant 
persistence at 3 and 6 month horizons, but the significant persistence at the 12 month 
horizon is associated with a PRW of less than 50%.  For the non-SRI funds there is a 
low PRW for 1 and 3 month horizons, with a significant with a chi squared test (at the 
10% level), but no evidence of significant persistence beyond that point.  However, at 
the 6 month horizon non-SRI funds exhibit marginally greater persistence than SRIs, 
and significantly greater positive persistence at the 12 month horizon, though at the 3 
month horizon SRI funds exhibit marginally greater significance.  Finally, note that 
taken as a whole, our findings on persistence at the 12 month horizon are compatible 
with those in Tonks (2002) and Gregory and Tonks (2005) 
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Our final tests for persistence involve partitioning funds into quartiles based on their 
prior 12 months’ performance.  We carry out tests using absolute, 3-factor abnormal 
returns, and 4-factor abnormal returns as the ranking measure.  Funds are put into 
portfolios according to prior performance, and these returns regressed on factors for 
the following 12 months.  As with the winner-loser tests we use overall sample cut-
offs to determine portfolio membership.  We are not able to do this test for the 
international funds because there are simply too few funds to form meaningful 
quartile portfolios.  In Table 11 we report results for the 3-factor model.  The rows of 
the Table report regression results for the quartiles 1 (best prior performance) to 4 
(worst prior performance), whilst the columns show results for the overall sample, and 
the SRI and non-SRI sub-samples.  The last rows in the table report results for the 
“winner” (Q1) minus the “loser” (Q4) portfolio.  Note that in contrast to Table 7, 
these results are for portfolios of funds formed in calendar time and then regressed on 
factors and, of course, partitioning is by quartile rather than median performance.  For 
the overall results note that only the bottom quartile of funds have significantly 
persistent performance (at the 10% level), which is negative.  The winner-loser 
portfolio exhibits significant positive persistence, and intriguingly a highly significant 
negative exposure to HML.  For the SRI group, a more significant negative 
persistence is observed for Q4, with a similar result to the overall sample being seen 
for the winner-loser portfolio.  However, for the non-SRI group whilst the Q4 
performance is significantly negative (at the 10% level), the performance of the 
winner-loser portfolio is not significantly different from zero, although the SMB 
loading is significantly positive and the HML loading is significantly negative. 
 
Table 12 reports these results based upon a four-factor model.  Overall, only the Q3 
portfolio exhibits performance persistence, which is negative.  Intriguingly, whilst the 
hedge portfolio now exhibits weakly positive persistence, not only is the HML 
loading significantly negative but the SMB and momentum loadings are significantly 
positive.  For the SRI sub-sample, both Q3 and Q4 exhibit significantly negative 
performance.  The hedge portfolio has significant positive performance and a 
significantly negative HML loading.  However, none of the non-SRI portfolios show 
significant performance, and neither is there any significant difference in 
performance. 
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Last, in Table 13, we report results where prior absolute performance determines 
quartile membership.  As a result, we use three benchmarks for post-formation 
performance: a 1-factor model; a 3-factor model; and a 4-factor model.  Turning to 
the overall portfolio first, we observe no persistence in performance when a single 
factor model is employed, although the “hedge” portfolio does exhibit significant 
performance at the 10% level.  When we switch to a 3-factor model we observe 
negative persistence (significant at the 10% level) in the Q4 portfolio, and a 
significant negative persistence for the hedge portfolio.  This persistence is 
maintained when we move to a 4-factor model.   For the SRI funds there is no 
persistence under the single factor model, although the hedge portfolio has significant 
persistence at the 10% level.  Under the 3-factor model none of the quartile portfolios 
exhibit significant persistence but again the hedge portfolio has significantly positive 
performance and a significantly negative HML exposure.  A similar story applies 
under a 4-factor model, although under this model we see a significant positive 
exposure to the momentum effect in the W-L portfolio.  Non-SRI funds exhibit no 
significant persistence under any model, and neither does the hedge portfolio exhibit 
any persistence.  The major message from these regressions is that “ethical” investors 
may be well advised to avoid funds that have exhibited poor performance over the 
previous 12 months in favour of those which have exhibited superior performance. 
 
One possible factor in explaining our findings on persistence may be the “UK smaller 
companies” persistence result for Blake and Timmerman (1998).  On a risk-adjusted 
basis, they find a difference between top and bottom quartile performers in excess of 
0.5% per month for this group, as opposed to around 0.1% for the UK general group 
of funds.  As we report above, SRI funds are significantly more exposed to the SMB 
factor than the control group, which may play an important role in explaining the 
difference in persistence between the two groups. 
 
Conclusions 
Using UK style portfolios that are free of any survivorship bias we have examined 
performance and persistence in performance of UK “ethical” or SRI funds, and 
compared them to a control group of non-SRI funds.  In addition, given the evidence 
that many UK funds which claim to be international in nature may exhibit home bias 
in their portfolio allocations, we have proposed a measure for performance of 
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international funds that picks up this “home bias”, and we further show that such 
recognition has important implications for conclusion drawn on performance.  These 
initial tests show that SRI funds have less exposure to HML, but greater exposure to 
SMB and momentum factors.  However, neither SRI nor non-SRI funds exhibit 
significant under performance on a risk/style adjusted basis, despite comparatively 
poor absolute performance.  In addition, we show that performance appears to be 
time-varying, and that conclusions on performance itself are influenced by whether a 
static or time varying model is employed. That said, we do not show unambiguously 
significant positive out-performance, but we do show that on a time varying basis, net 
of risk/style effects, domestic SRI funds may out-perform their control group of non-
SRI funds, although this is only true for calendar time portfolios.  Last, we have 
examined persistence in fund performance and find evidence that supports 
persistence.  In addition, we find there are differences in performance persistence 
between ethical and non-ethical funds, but, as in Fletcher and Forbes (2002) 
conclusions on the degree of persistence and the direction of persistence appear to 
depend on the performance metric chosen.  However, it is unambiguously the case 
that past winner “ethical” funds outperform “loser” ethical funds at 12 month 
horizons.  In conclusion, although absolute returns are low and the style exposure of 
ethical funds, particularly domestic funds, looks very different to that of ordinary 
funds our findings do not suggest that ethical investors lose out compared to 
“ordinary” investors.  However, there is evidence that “ethical” investors can enhance 
investment performance by investing in past “winners” and avoiding past “losers” 
however risk and style effects are controlled for. 
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Table 1:  Basic stats: 
 
Absolute performance: 
Domestic 
AVERAGES: MONTHLY ANNUALISED FINAL WEALTH ANNUALISED SD 
SRI 0.62% 7.75% 2.487053382 13.76% 
Non- SRI 0.67% 8.35% 2.591774833 15.59% 
Rm (FTASI) 0.83% 10.48%  
Difference -0.05% -0.56%  
Rf 0.59% 7.26%  
 
International: 
AVERAGES: MONTHLY ANNUALISED FINAL WEALTH ANNUALISED SD 
SRI 0.54% 6.64% 2.102313177 14.95%
Non- SRI 0.62% 7.72% 2.434036369 14.68%
Rm (MSCI World) 1.22% 15.65% 
Difference -0.08% -1.01% 
Rf 0.59% 7.26% 
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Table 2: Basic Jensen model coefficients  
 
DOMESTIC, BASIC JENSEN 
ALPHAS SRI Non SRI Hedge 
1-factor Coefficient T-test Coefficient T-test Coefficient T-test 
Rm - Rf 0.794 24.42 0.974 42.58 -0.180 -7.07
CONSTANT -0.002 -1.10 -0.002 -1.55 0.000 -0.02
Adj R2 0.781  0.916  0.227  
3-factor Coefficient T-test Coefficient T-test Coefficient T-test 
Rm - Rf 0.805 28.37 0.974 46.67 -0.169 -7.10
SMB 0.246 6.70 0.164 6.08 0.082 2.65
HML -0.039 -1.16 0.059 2.36 -0.098 -3.44
CONSTANT -0.001 -0.45 -0.001 -1.25 0.001 0.56
Adj R2 0.835  0.930  0.328  
4-factor Coefficient T-test Coefficient T-test Coefficient T-test 
Rm - Rf 0.816 27.64 0.970 44.47 -0.154 -6.27
SMB 0.258 6.84 0.160 5.73 0.098 3.12
HML -0.025 -0.70 0.054 2.06 -0.078 -2.66
MOM 0.059 1.34 -0.020 -0.60 0.079 2.15
CONSTANT -0.001 -0.64 -0.001 -1.16 0.000 0.26
Adj R2 0.836  0.930  0.342  
 
INTERNATIONAL, BASIC
JENSEN ALPHAS SRI NON SRI HEDGE 
3-factor, multi Coefficient T-test Coefficient T-test Coefficient T-test 
HOME (=Rm-Rw) 0.498 11.29 0.446 11.94 0.052 1.18
Rw-Rf 0.858 33.11 0.900 41.02 -0.041 -1.58
HOMESMB (=SMB-SMBw) 0.196 5.68 0.057 1.94 0.139 4.01
SMBw 0.464 11.10 0.214 6.05 0.250 5.95
HOMEHML (=HML-HMLw) -0.004 -0.12 0.021 0.79 -0.025 -0.78
HMLw -0.046 -1.23 0.008 0.27 -0.054 -1.45
CONSTANT -0.001 -1.24 -0.001 -1.02 0.000 -0.37
Adj R2 0.891  0.919  0.203  
4-factor, multi Coefficient T-test Coefficient T-test Coefficient T-test 
HOME (=Rm-Rw) 0.501 11.27 0.448 11.93 0.053 1.18
Rw-Rf 0.865 29.88 0.906 37.01 -0.041 -1.40
HOMESMB (=SMB-SMBw) 0.204 5.59 0.064 2.07 0.140 3.81
SMBw 0.467 11.01 0.216 6.04 0.250 5.86
HOMEHML (=HML-HMLw) 0.003 0.09 0.027 0.98 -0.024 -0.73
HMLw -0.037 -0.79 0.017 0.43 -0.054 -1.15
HOME MOM (=MOM – MOMw) 0.036 0.81 0.033 0.89 0.003 0.06
MOMw 0.028 0.60 0.027 0.67 0.002 0.03
CONSTANT -0.001 -1.18 -0.001 -0.99 0.000 -0.34
Adj R2 0.890  0.918  0.193  
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Table 3: Jensen model with timing (note national only): 
TIMING REGRESIONS, 
NATIONAL SRI NON SRI HEDGE 
1-factor Coefficient T-test Coefficient T-test Coefficient T-test 
Rm - Rf 0.785 24.940 0.968 43.230 -0.184 -7.256
(Rm – Rf)
2
 -1.764 -3.701 -1.038 -3.059 -0.726 -1.890
CONSTANT 0.002 1.130 0.000 0.404 0.001 1.047
Adj R2 0.797   0.920   0.238  
3-factor Coefficient T-test Coefficient T-test Coefficient T-test 
Rm - Rf 0.805 32.000 0.976 49.290 -0.171 -7.278
SMB 0.293 8.468 0.193 7.093 0.100 3.094
HML -0.081 -2.505 0.042 1.647 -0.122 -4.075
(Rm – Rf)
2
 -1.256 -3.277 -0.682 -2.260 -0.574 -1.606
SMB
2
 -0.604 -1.140 -0.597 -1.432 -0.007 -0.014
HML
2
 1.693 5.208 1.011 3.951 0.682 2.250
CONSTANT 0.000 0.287 0.000 -0.405 0.001 0.649
Adj R2 0.874   0.939   0.366  
4-factor Coefficient T-test Coefficient T-test Coefficient T-test 
Rm - Rf 0.813 31.320 0.971 46.710 -0.157 -6.502
SMB 0.325 8.909 0.193 6.639 0.131 3.865
HML -0.064 -1.925 0.036 1.358 -0.101 -3.235
MOM 0.050 1.302 -0.023 -0.742 0.072 2.036
(Rm – Rf)
2
 -1.102 -2.870 -0.655 -2.133 -0.447 -1.250
SMB
2
 -0.819 -1.545 -0.617 -1.455 -0.202 -0.409
HML
2
 1.898 5.699 1.056 3.963 0.842 2.716
MOM 
2
 -1.179 -2.116 -0.327 -0.733 -0.853 -1.644
CONSTANT 0.001 0.768 0.000 -0.085 0.001 0.898
Adj R2 0.877   0.939   0.385  
Conditional 1-factor Coefficient T-test Coefficient T-test Coefficient T-test 
Rm - Rf 0.795 22.44 0.976 38.67 -0.181 -6.53
DY(Rm – Rf) -0.074 -0.96 0.009 0.17 -0.083 -1.38
TB(Rm – Rf) -0.010 -0.29 -0.013 -0.49 0.002 0.08
TERM(Rm – Rf) -0.031 -0.68 -0.015 -0.46 -0.016 -0.45
JAN(Rm – Rf) -0.159 -1.48 -0.174 -2.26 0.014 0.17
CONSTANT -0.001 -0.58 -0.001 -1.37 0.001 0.51
Adj R2 0.789  0.917  0.255  
Conditional 3-factor Coefficient T-test Coefficient T-test Coefficient T-test 
Rm - Rf 0.804 26.24 0.975 42.27 -0.171 -6.62
SMB 0.248 6.91 0.160 5.90 0.089 2.92
HML -0.030 -0.92 0.060 2.43 -0.091 -3.26
DY(Rm – Rf) -0.087 -1.30 -0.005 -0.11 -0.082 -1.45
TB(Rm – Rf) -0.005 -0.15 -0.008 -0.34 0.003 0.13
TERM(Rm – Rf) -0.027 -0.67 -0.012 -0.41 -0.014 -0.43
JAN(Rm – Rf) -0.092 -0.98 -0.140 -1.99 0.048 0.61
CONSTANT 0.000 0.14 -0.001 -1.04 0.001 1.09
Adj R2 0.843  0.931  0.357  
Conditional 4-factor Coefficient T-test Coefficient T-test Coefficient T-test 
Rm - Rf 0.814 26.12 0.972 41.19 -0.159 -6.09
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SMB 0.263 7.10 0.156 5.56 0.107 3.45
HML -0.014 -0.40 0.056 2.13 -0.070 -2.41
MOM 0.068 1.55 -0.019 -0.56 0.087 2.36
DY(Rm – Rf) -0.063 -0.93 -0.012 -0.23 -0.051 -0.90
TB(Rm – Rf) -0.017 -0.55 -0.004 -0.19 -0.013 -0.49
TERM(Rm – Rf) -0.041 -1.01 -0.008 -0.27 -0.033 -0.97
JAN(Rm – Rf) -0.088 -0.94 -0.141 -2.00 0.053 0.68
CONSTANT 0.000 -0.11 -0.001 -0.93 0.001 0.72
Adj R2 0.845  0.931  0.374  
 
Note: for international portfolios no timing effects are ever significant 
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Table 4:  Time varying coefficients 
Domestic: 
3 factor 
3 FACTOR BETA GAMMA  DELTA ALPHA 
SRI mean 0.778917 0.352202 -0.06794 0.000972
SRI p 0.000 0.000 0.187 0.219
Non-SRI mean 0.96034 0.17844 0.044741 -0.0005
Non-SRI p 0.000 0.000 0.082 0.157
Hedge Mean -0.18142 0.173762 -0.11268 0.001468
Hedge p 0.000 0.002 0.006 .0004732
Hedge change, 2
nd
 period .1623931 .1227636 -.0392513 .0019134
Hedge change p 0.000 0.070 0.486 0.0000
 
 
4 factor 
4-FACTOR BETA GAMMA  DELTA LAMBDA ALPHA 
SRI mean 0.795184 0.381075 -0.04341 0.085172 0.001029
SRI p 0.000 0.000 0.254 0.092 0.268
Non-SRI mean 0.962347 0.156682 0.037392 -0.04283 -0.00031
Non-SRI p 0.000 0.000 0.023 0.355 0.433
Hedge Mean -0.16716 0.224393 -0.08081 0.128 0.001342
Hedge p 0.000 0.000 0.031 0.000 .0002577
Hedge change, 2
nd
 period .1609086 .0399318 -.0632784 .0396967 .0021641
Hedge change p 0.000 0.567 0.191 0.042 0.0000
 
 
International 
3-FACTOR BETA GAMMA  DELTA HOME B HOME S HOME H ALPHA 
SRI mean 0.508197 0.857764 0.293561 0.542898 -0.03286 -0.01283 -0.00042
SRI p 0.000 0.000 0.000 0.000 0.175 0.575 0.613
Non-SRI mean 0.460533 0.927012 0.072141 0.219392 0.036887 0.086299 -0.00255
Non-SRI p 0.000 0.000 0.001 0.000 0.313 0.064 0.000
Hedge Mean 0.047664 -0.06925 0.22142 0.323506 -0.06975 -0.09913 0.002135
Hedge p . 0.103 0.003 0.000 0.000 0.068 0.024 0.141
Hedge change, 2
nd
 
period .127196 -.060097 -.009535 .027723 .095421 .029652 .003064
Hedge change p 0.000 0.060 0.893 0.700 0.120 0.712 0.1491
 
See also figures 1-6 attached 
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Table 5: Average monthly abnormal returns from time-varying model 
 
GROUP 
3 FACTOR 
DOMESTIC 
4 FACTOR 
DOMESTIC 
3 FACTOR 
INTERNATIONAL 
SRI mean 0. 20% 0.09% 0.11%
p-value 0.01 0.26 0.33
Non-SRI mean 0. 06% 0.04% 0.03%
p-value 0.16 0.34 0.68
Difference 0.14% 0.07% 0.08%
p-value of T-test for difference 0.15 0.62 0.53
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Table 6: Short horizon Contingency tables of scheme performance – absolute 
performance 
Overall Sample: absolute performance, domestic 
STATISTIC 1-MONTH 3-MONTH 6-MONTH 12-MONTH
PRW 0.5095908 0.4989691 0.5492662 0.5188679
CP ratio 1.0687585 0.9437504 1.4357689 1.6927083
SD CP 0.0715299 0.1284508 0.1839082 0.2777176
Z 0.4037413 -0.195739 0.8541464 0.8230741
Chi 0.8772379 0.2762887 3.9308176 4.7924528
p Chi 0.349 0.599 0.047 0.029
 
Ethicals Sub-sample: absolute performance, domestic 
STATISTIC 1-MONTH 3-MONTH 6-MONTH 12-MONTH
PRW 0.4875267 0.4572748 0.4549763 0.3655914
CP ratio 1.1023769 1.02 1.301627 0.9807692
SD CP 0.1068862 0.1926632 0.2776732 0.4249922
Z 0.3960298 0.0446384 0.4123069 -0.019843
Chi 2.6421953 1.9838337 3.957346 4.4193548
p Chi 0.104 0.159 0.047 0.036
 
 
Non-Ethicals sub-sample: absolute performance, domestic 
STATISTIC 1-MONTH 3-MONTH 6-MONTH 12-MONTH
PRW 0.5275362 0.5325885 0.6240602 0.6386555
CP ratio 1.0381291 0.8724969 1.500565 2.5189394
SD CP 0.0963614 0.1731622 0.2475662 0.3768401
Z 0.1686501 -0.342085 0.7119503 1.0646897
Chi 1.9356522 3.1489758 5.6691729 6.3445378
p Chi 0.164*** 0.076*** 0.017*** 0.012***
 
Schemes are classified as winners or losers based on abnormal returns in each of two 
consecutive time periods, and the numbers of winner-winner (WW), winner-loser 
(WL), loser winner (LW) and loser-loser (LL) are counted. The following statistics 
are computed: a) Percentage of repeat winners, PRW = WW/(N/2); b) Cross-product 
ratio CP = (WW x LL)/(WL x LW); where  log(CP)/σlog(CP)  has a standard normal 
distribution, and  σlog(CP) = √[(1/WW) + (1/WL) + (1/LW) + (1/LL)]; c) Chi-Squared 
test with 1 d.o.f. where CHI = {(WW - N/4)
2
 + (WL - N/4)
2
  + (LW - N/4)
2
 (LL - 
N/4)
2
}/N/4, and N is the number of pairs; * denotes ethical/control persistence is 
significantly above the control/ethical group at the 10% level; ** denotes 
ethical/control persistence is significantly above the control/ethical group at the 5% 
level; *** denotes ethical/control persistence is significantly above the control/ethical 
group at the 1% level. 
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Table 7: Short horizon Contingency tables of scheme performance – 3 factor 
model 
Overall Sample: 3 factor domestic 
STATISTIC 1-MONTH 3-MONTH 6-MONTH 12-MONTH
PRW 0.46948 0.4692875 0.4887781 0.5340909
CP ratio 0.7902599 0.7149733 1.0919504 1.6491228
SD CP 0.0777789 0.1407141 0.1999004 0.3040792
Z -1.314368 -1.035506 0.1911098 0.7144618
Chi 9.1770912 5.8820639 0.6259352 3.0454545
p Chi 0.002 0.015 0.429 0.081
 
Ethicals Sub-sample: 3 factor domestic 
STATISTIC 1-MONTH 3-MONTH 6-MONTH 12-MONTH
PRW 0.467354 0.5183099 0.5747126 0.5405405
CP ratio 0.8023343 0.6917293 0.978836 1.125
SD CP 0.1174246 0.2142094 0.3050554 0.4669642
Z -0.81452 -0.74723 -0.030454 0.1095427
Chi 3.6082474 5.484507 2.045977 0.5945946
p Chi 0.057 0.019** 0.153*** 0.441**
 
 
Non-Ethicals sub-sample: 3 factor domestic 
STATISTIC 1-MONTH 3-MONTH 6-MONTH 12-MONTH
PRW 0.4711409 0.4313725 0.4229075 0.5294118
CP ratio 0.7809076 0.7213115 1.1313131 2.1961722
SD CP 0.1038245 0.1875175 0.2679914 0.405629
Z -1.034441 -0.756608 0.1999424 0.8423125
Chi 5.704698 3.788671 4.6299559 5.0588235
p Chi 0.017 0.052 0.031 0.025
 
Schemes are classified as winners or losers based on abnormal returns in each of two 
consecutive time periods, and the numbers of winner-winner (WW), winner-loser 
(WL), loser winner (LW) and loser-loser (LL) are counted. The following statistics 
are computed: a) Percentage of repeat winners, PRW = WW/(N/2); b) Cross-product 
ratio CP = (WW x LL)/(WL x LW); where  log(CP)/σlog(CP)  has a standard normal 
distribution, and  σlog(CP) = √[(1/WW) + (1/WL) + (1/LW) + (1/LL)]; c) Chi-Squared 
test with 1 d.o.f. where CHI = {(WW - N/4)
2
 + (WL - N/4)
2
  + (LW - N/4)
2
 (LL - 
N/4)
2
}/N/4, and N is the number of pairs; * denotes ethical/control persistence is 
significantly above the control/ethical group at the 10% level; ** denotes 
ethical/control persistence is significantly above the control/ethical group at the 5% 
level; *** denotes ethical/control persistence is significantly above the control/ethical 
group at the 1% level. 
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Table 8: Short horizon Contingency tables of scheme performance – 4 factor 
model 
Overall Sample: 4 factor domestic 
STATISTIC 1-MONTH 3-MONTH 6-MONTH 12-MONTH
PRW 0.4807837 0.4373464 0.4588529 0.6363636
CP ratio 0.8445789 0.647591 0.8424908 3.5526882
SD CP 0.0777138 0.1410412 0.2000219 0.316856
Z -0.943973 -1.337902 -0.372133 1.7375627
Chi 4.7460437 9.6363636 1.0448878 16.681818
p Chi 0.029 0.002 0.307 0.000
 
Ethicals Sub-sample: 4 factor domestic 
STATISTIC 1-MONTH 3-MONTH 6-MONTH 12-MONTH
PRW 0.475945 0.4619718 0.5172414 0.6216216
CP ratio 0.9646862 0.5991392 1.0963455 1.7137255
SD CP 0.1172935 0.2142703 0.3033395 0.4707441
Z -0.133118 -1.038278 0.1316922 0.4969605
Chi 0.9965636 6.3633803 0.1149425 1.8918919
p Chi 0.318 0.012* 0.735* 0.169
 
 
Non-Ethicals sub-sample: 4 factor domestic 
STATISTIC 1-MONTH 3-MONTH 6-MONTH 12-MONTH
PRW 0.4845638 0.4183007 0.4140969 0.6470588
CP ratio 0.7589013 0.6829268 0.6847034 6.3461538
SD CP 0.1039144 0.1878505 0.2671924 0.4412778
Z -1.153013 -0.881689 -0.615652 1.8186063
Chi 8.0348993 5.2527233 2.6563877 20.117647
p Chi 0.005*** 0.022 0.103 0.000***
 
Schemes are classified as winners or losers based on abnormal returns in each of two 
consecutive time periods, and the numbers of winner-winner (WW), winner-loser 
(WL), loser winner (LW) and loser-loser (LL) are counted. The following statistics 
are computed: a) Percentage of repeat winners, PRW = WW/(N/2); b) Cross-product 
ratio CP = (WW x LL)/(WL x LW); where  log(CP)/σlog(CP)  has a standard normal 
distribution, and  σlog(CP) = √[(1/WW) + (1/WL) + (1/LW) + (1/LL)]; c) Chi-Squared 
test with 1 d.o.f. where CHI = {(WW - N/4)
2
 + (WL - N/4)
2
  + (LW - N/4)
2
 (LL - 
N/4)
2
}/N/4, and N is the number of pairs; * denotes ethical/control persistence is 
significantly above the control/ethical group at the 10% level; ** denotes 
ethical/control persistence is significantly above the control/ethical group at the 5% 
level; *** denotes ethical/control persistence is significantly above the control/ethical 
group at the 1% level. 
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Table 9: Short horizon Contingency tables of scheme performance – absolute 
performance, international 
Overall Sample: absolute performance, international 
STATISTIC 1-MONTH 3-MONTH 6-MONTH 12-MONTH
PRW 0.4961581 0.5224396 0.5336427 0.5771144
CP ratio 0.9725739 1.2078695 1.1482988 1.86268
SD CP 0.0765157 0.1358421 0.1928359 0.2855663
Z -0.157842 0.6037892 0.3114302 0.9459739
Chi 0.1328211 1.9367089 0.74942 4.7910448
p Chi 0.716 0.164 0.387 0.029
 
Ethicals Sub-sample: absolute performance, international 
STATISTIC 1-MONTH 3-MONTH 6-MONTH 12-MONTH
PRW 0.460443 0.52 0.5076142 0.4888889
CP ratio 0.8627769 1.3768322 1.352657 2.0058824
SD CP 0.1126409 0.2007321 0.2860393 0.4318983
Z -0.569078 0.6918725 0.4586351 0.6999459
Chi 2.8291139 2.96 1.5177665 4.8444444
p Chi 0.093 0.085 0.218 0.028
 
 
Non-Ethicals sub-sample: absolute performance, international 
STATISTIC 1-MONTH 3-MONTH 6-MONTH 12-MONTH
PRW 0.526889 0.5245203 0.5555556 0.6486486
CP ratio 1.075 1.0791922 0.9877265 1.6904348
SD CP 0.1044123 0.18479 0.2623088 0.3850884
Z 0.300812 0.1791157 -0.020447 0.5920677
Chi 1.4179714 0.4498934 1.4529915 3.5585586
p Chi 0.234*** 0.502* 0.228** 0.059**
 
Schemes are classified as winners or losers based on abnormal returns in each of two 
consecutive time periods, and the numbers of winner-winner (WW), winner-loser 
(WL), loser winner (LW) and loser-loser (LL) are counted. The following statistics 
are computed: a) Percentage of repeat winners, PRW = WW/(N/2); b) Cross-product 
ratio CP = (WW x LL)/(WL x LW); where  log(CP)/σlog(CP)  has a standard normal 
distribution, and  σlog(CP) = √[(1/WW) + (1/WL) + (1/LW) + (1/LL)]; c) Chi-Squared 
test with 1 d.o.f. where CHI = {(WW - N/4)
2
 + (WL - N/4)
2
  + (LW - N/4)
2
 (LL - 
N/4)
2
}/N/4, and N is the number of pairs; * denotes ethical/control persistence is 
significantly above the control/ethical group at the 10% level; ** denotes 
ethical/control persistence is significantly above the control/ethical group at the 5% 
level; *** denotes ethical/control persistence is significantly above the control/ethical 
group at the 1% level. 
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Table 10: Short horizon Contingency tables of scheme performance – multi-
factor model, international 
Overall Sample: multi-factor international 
STATISTIC 1-MONTH 3-MONTH 6-MONTH 12-MONTH
PRW 0.4700565 0.460396 0.5429234 0.5572139
CP ratio 0.8532325 0.7725857 1.3590909 1.7167019
SD CP 0.0776995 0.141022 0.1932451 0.2847483
Z -0.887169 -0.794581 0.6895311 0.8242187
Chi 4.7016949 3.4455446 2.549884 3.6766169
p Chi 0.030 0.063 0.110 0.055
 
Ethicals Sub-sample: multi-factor international 
STATISTIC 1-MONTH 3-MONTH 6-MONTH 12-MONTH
PRW 0.4669528 0.5055556 0.5177665 0.4888889
CP ratio 0.8619015 0.7431764 1.5278926 2.0058824
SD CP 0.1172999 0.2118637 0.2868863 0.4318983
Z -0.550234 -0.608448 0.6416925 0.6999459
Chi 2.0901288 3.2666667 2.7360406 4.8444444
p Chi 0.148 0.071** 0.098 0.028
 
 
Non-Ethicals sub-sample: multi-factor international 
STATISTIC 1-MONTH 3-MONTH 6-MONTH 12-MONTH
PRW 0.4241071 0.4264392 0.5641026 0.6126126
CP ratio 0.7849003 0.8132231 1.2214286 1.4711538
SD CP 0.1898087 0.1854577 0.2621723 0.3828538
Z -0.554166 -0.484155 0.3313396 0.4379168
Chi 3.5178571 3.4520256 1.3162393 2.045045
p Chi 0.061 0.063 0.251* 0.153**
 
Schemes are classified as winners or losers based on abnormal returns in each of two 
consecutive time periods, and the numbers of winner-winner (WW), winner-loser 
(WL), loser winner (LW) and loser-loser (LL) are counted. The following statistics 
are computed: a) Percentage of repeat winners, PRW = WW/(N/2); b) Cross-product 
ratio CP = (WW x LL)/(WL x LW); where  log(CP)/σlog(CP)  has a standard normal 
distribution, and  σlog(CP) = √[(1/WW) + (1/WL) + (1/LW) + (1/LL)]; c) Chi-Squared 
test with 1 d.o.f. where CHI = {(WW - N/4)
2
 + (WL - N/4)
2
  + (LW - N/4)
2
 (LL - 
N/4)
2
}/N/4, and N is the number of pairs; * denotes ethical/control persistence is 
significantly above the control/ethical group at the 10% level; ** denotes 
ethical/control persistence is significantly above the control/ethical group at the 5% 
level; *** denotes ethical/control persistence is significantly above the control/ethical 
group at the 1% level. 
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Table 11: Performance conditioned on prior 12 months’ abnormal performance 
– 3 factor model 
QUARTILE OVERALL SRI NON-SRI 
Q1 Coef't T-ratio Coef't T-ratio Coef't T-ratio 
Rm - Rf 0.872 18.23 0.806 12.4 0.917 19.49 
SMB 0.229 4.199 0.225 3.037 0.239 4.455 
HML -0.105 -2.234 -0.133 -2.095 -0.05 -1.092 
CONSTANT 0.002 1.026 0.002 0.823 0.001 0.576 
Adusted R2  0.747  0.586  0.791 
Q2 Coef't T-ratio Coef't T-ratio Coef't T-ratio 
Rm - Rf 0.942 34.35 0.921 19.24 0.976 39.22 
SMB 0.153 4.885 0.224 4.174 0.113 4.018 
HML 0.037 1.362 0.063 1.261 0.038 1.567 
CONSTANT 0 -0.353 0 -0.23 -0.001 -0.882 
Adusted R2  0.909  0.793  0.932 
Q3 Coef't T-ratio Coef't T-ratio Coef't T-ratio 
Rm - Rf 0.92 37.49 0.916 21.76 0.933 39.2 
SMB 0.089 3.192 0.189 3.836 0.044 1.619 
HML 0.068 2.833 0.105 2.314 0.06 2.556 
CONSTANT -0.001 -1.173 -0.002 -1.377 0 -0.393 
Adusted R2  0.923  0.835  0.929 
Q4 Coef't T-ratio Coef't T-ratio Coef't T-ratio 
Rm - Rf 0.864 31.99 0.753 20.82 0.913 33.02 
SMB 0.149 4.846 0.243 6.093 0.081 2.564 
HML 0.095 3.583 0.095 2.823 0.139 5.158 
CONSTANT -0.002 -1.685 -0.004 -2.67 -0.002 -1.743 
Adusted R2  0.898  0.811  0.905 
W-L Coef't T-ratio Coef't T-ratio Coef't T-ratio 
Rm - Rf 0.008 0.174 0.022 0.318 0.02 0.362 
SMB 0.08 1.512 -0.057 -0.761 0.154 2.5 
HML -0.199 -4.401 -0.231 -3.645 -0.179 -3.4 
CONSTANT 0.004 2.044 0.007 2.687 0.004 1.544 
Adusted R2  0.19  0.095  0.197 
 
Q1-Q4 denotes prior performance quartile (Q1 is highest, Q4 lowest). W-L is 
“winner” (highest quartile prior performance) minus “loser” (lowest quartile prior 
performance) or “hedge” portfolio performance.
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Table 12: Performance conditioned on prior 12 months’ abnormal performance 
– 4 factor model 
QUARTILE OVERALL SRI NON-SRI 
Q1 Coef't T-ratio Coef't T-ratio Coef't T-ratio 
Rm - Rf 0.914 19.09 0.849 12.23 0.937 20.28 
SMB 0.261 4.903 0.216 2.799 0.273 5.278 
HML -0.057 -1.217 -0.114 -1.676 0.036 0.801 
WML 0.111 1.814 0.114 1.282 0.098 1.672 
CONSTANT 0.001 0.698 0.002 0.804 0 -0.097 
Adusted R2  0.769  0.581  0.802 
Q2 Coef't T-ratio Coef't T-ratio Coef't T-ratio 
Rm - Rf 0.889 27.88 0.83 13.85 0.931 30.14 
SMB 0.149 4.207 0.234 3.771 0.078 2.325 
HML 0.013 0.416 0.025 0.443 0.013 0.425 
WML -0.039 -0.955 -0.046 -0.559 -0.03 -0.764 
CONSTANT 0.001 0.898 0.001 0.63 0.001 0.9 
Adusted R2  0.878  0.675  0.903 
Q3 Coef't T-ratio Coef't T-ratio Coef't T-ratio 
Rm - Rf 0.92 40.02 0.892 24.22 0.926 40.37 
SMB 0.1 3.91 0.235 5.688 0.033 1.297 
HML 0.057 2.525 0.092 2.508 0.043 1.909 
WML -0.019 -0.646 0.042 0.881 -0.025 -0.853 
CONSTANT -0.002 -2.025 -0.004 -2.728 -0.001 -1.093 
Adusted R2  0.936  0.865  0.938 
Q4 Coef't T-ratio Coef't T-ratio Coef't T-ratio 
Rm - Rf 0.874 30.84 0.797 20.59 0.903 30.43 
SMB 0.118 3.748 0.18 4.348 0.054 1.654 
HML 0.07 2.511 0.07 1.942 0.068 2.34 
WML -0.05 -1.385 -0.023 -0.496 -0.151 -3.994 
CONSTANT -0.002 -1.467 -0.003 -2.015 -0.001 -0.712 
Adusted R2  0.899  0.816  0.905 
W-L Coef't T-ratio Coef't T-ratio Coef't T-ratio 
Rm - Rf 0.039 0.902 0.028 0.39 0.034 0.688 
SMB 0.143 2.95 -0.01 -0.134 0.216 3.903 
HML -0.127 -2.974 -0.193 -2.855 -0.03 -0.624 
WML 0.161 2.897 0.131 1.49 0.253 4.063 
CONSTANT 0.003 1.723 0.007 2.512 0 0.241 
Adusted R2  0.246  0.095  0.259 
            
 
 
Q1-Q4 denotes prior performance quartile (Q1 is highest, Q4 lowest). W-L is 
“winner” (highest quartile prior performance) minus “loser” (lowest quartile prior 
performance) or “hedge” portfolio performance.
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Table 13: Performance conditioned on prior 12 months’ absolute performance – 1, 3 and 4 factor models 
 1-FACTOR 3-FACTOR 4-FACTOR 
 OVERALL SRI NON-SRI OVERALL SRI NON-SRI OVERALL SRI NON-SRI 
Q1 0.903 18.93 0.858 12.89 0.903 22.71 0.915 20.65 0.873 13.94 0.911 23.99 0.954 21.57 0.918 14.52 0.936 24.27 
Rm - Rf       0.136 2.70 0.133 1.88 0.123 2.83 0.161 3.28 0.162 2.32 0.139 3.23 
SMB       -0.106 -2.45 -0.164 -2.68 -0.041 -1.10 -0.066 -1.51 -0.116 -1.86 -0.015 -0.38 
HML             0.184 3.25 0.213 2.67 0.119 2.41 
WML 0.002 0.87 0.003 1.05 0.001 0.32 0.002 1.38 0.004 1.50 0.001 0.60 0.002 1.10 0.003 1.28 0.001 0.36 
CONSTANT  0.75  0.59  0.82  0.79  0.64  0.83  0.80  0.66  0.84 
Adusted R2 
Coef't T-ratio Coef't 
T-
ratio Coef't 
T-
ratio Coef't 
T-
ratio Coef't 
T-
ratio Coef't T-ratio Coef't 
T-
ratio Coef't 
T-
ratio Coef't T-ratio 
Q2 0.946 31.42 0.957 18.82 0.97 30.86 0.954 34.15 0.964 21.21 0.975 31.70 0.963 33.23 0.961 19.89 0.99 31.30 
Rm - Rf       0.114 3.57 0.2 3.97 0.079 2.25 0.119 3.70 0.198 3.87 0.089 2.52 
SMB       -0.039 -1.44 -0.046 -1.12 -0.019 -0.64 -0.031 -1.07 -0.049 -1.12 -0.004 -0.11 
HML             0.04 1.07 -0.011 -0.20 0.071 1.75 
WML 0 -0.35 0 -0.04 0 0.12 0 -0.01 0 0.09 0 0.33 0 -0.12 0 0.10 0 0.16 
CONSTANT  0.892  0.792  0.890  0.908  0.834  0.895  0.908  0.832  0.897 
Adusted R2 
Coef't T-ratio Coef't 
T-
ratio Coef't 
T-
ratio Coef't 
T-
ratio Coef't 
T-
ratio Coef't T-ratio Coef't 
T-
ratio Coef't 
T-
ratio Coef't T-ratio 
Q3 0.926 31.13 0.899 19.61 0.943 35.21 0.931 33.74 0.901 21.96 0.946 36.67 0.925 32.26 0.889 21.09 0.947 35.24 
Rm - Rf       0.145 4.61 0.247 5.31 0.097 3.30 0.141 4.42 0.237 5.04 0.098 3.28 
SMB       0.062 2.29 0.091 2.29 0.051 2.01 0.055 1.95 0.077 1.88 0.052 1.97 
HML             -0.03 -0.82 -0.064 -1.19 0.006 0.18 
WML -0.001 -1.23 -0.003 -1.37 -0.001 -0.94 -0.002 -1.36 -0.003 -1.60 -0.001 -1.05 -0.001 -1.27 -0.003 -1.49 -0.001 -1.06 
CONSTANT  0.891  0.780  0.912  0.906  0.824  0.919  0.906  0.825  0.918 
Adusted R2 
Coef't T-ratio Coef't 
T-
ratio Coef't 
T-
ratio Coef't 
T-
ratio Coef't 
T-
ratio Coef't T-ratio Coef't 
T-
ratio Coef't 
T-
ratio Coef't T-ratio 
Q4 0.844 23.14 0.772 17.62 1.002 26.75 0.849 25.74 0.779 19.01 0.995 27.66 0.824 24.77 0.761 18.02 0.956 26.86 
Rm - Rf       0.188 5.01 0.203 4.35 0.111 2.81 0.173 4.66 0.192 4.08 0.093 2.48 
SMB       0.119 3.68 0.091 2.27 0.089 2.70 0.093 2.84 0.072 1.73 0.058 1.78 
HML             -0.117 -2.75 -0.086 -1.60 -0.15 -3.57 
WML -0.002 -1.38 -0.003 -1.45 -0.001 -0.84 -0.002 -1.71 -0.003 -1.59 -0.002 -1.16 -0.002 -1.47 -0.002 -1.43 -0.001 -1.01 
CONSTANT  0.818  0.722  0.879  0.852  0.758  0.889  0.860  0.761  0.902 
Adusted R2 
Coef't T-ratio Coef't 
T-
ratio Coef't 
T-
ratio Coef't 
T-
ratio Coef't 
T-
ratio Coef't T-ratio Coef't 
T-
ratio Coef't 
T-
ratio Coef't T-ratio 
W-L 0.059 1.12 0.073 1.04 -0.103 -1.93 0.067 1.37 0.084 1.27 -0.092 -1.80 0.129 2.83 0.146 2.24 -0.023 -0.48 
Rm - Rf       -0.052 -0.94 -0.064 -0.85 0.029 0.51 -0.012 -0.23 -0.023 -0.32 0.06 1.18 
SMB       -0.225 -4.73 -0.248 -3.86 -0.128 -2.72 -0.159 -3.54 -0.181 -2.84 -0.071 -1.62 
HML             0.301 5.16 0.299 3.64 0.271 4.74 
WML 0.004 1.74 0.005 1.89 0.002 0.88 0.005 2.42 0.006 2.37 0.003 1.33 0.004 2.14 0.005 2.13 0.002 1.18 
CONSTANT  0.002  0.001  0.028  0.154  0.106  0.110  0.307  0.195  0.280 
 36
Adusted R2 0.903 18.93 0.858 12.89 0.903 22.71 0.915 20.65 0.873 13.94 0.911 23.99 0.954 21.57 0.918 14.52 0.936 24.27 
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Figure 1: Rolling Calendar Time 4-factor Alphas, Domestic 
Calendar Time 3-Factor Alphas - Domestic
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Figure 2: Rolling Calendar Time 4-factor Alphas, Domestic
Calendar Time 4-Factor Alphas
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Figure 3: Rolling Calendar Time multi-factor Alphas, International 
Calendar Time 3-Factor Alphas - International
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Figure 4: Rolling Calendar Time 3-factor Hedge Fund coefficients, Domestic 
Hedge portfolio coefficients - 3 factor Domestic
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Figure 5: Rolling Calendar Time 4-factor Hedge Fund coefficients, Domestic 
Hedge portfolio coefficients
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Figure 6: Rolling Calendar Time multi-factor Hedge Fund coefficients, Domestic  
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